Established in 2003, OpSens Medical, a division of OpSens (TSX:OPS), was founded on the belief that their innovative technologies would help to improve cardiovascular disease diagnosis and treatment.
Today, their 2nd generation fiber optic OptoWire has been used in over 100,000 patients worldwide and their clinical partners use the products to improve their success rates in challenging peripheral and coronary interventions.
They pursue robust growth, through their own initiatives and key alliances with exemplary partners and commit themselves to provide solutions to medical professional and patient needs.
OpSens Announces Record Revenue for Second Quarter Fiscal 2023
OpSens Announces Completion of Enrollment in SAFE-TAVI Study With SavvyWire in Europe
OpSens Announces 1,000th SavvyWire® Procedure
OpSens Announces SavvyWire™ Used During Two Live Cases at CRT Conferen
OpSens Announces Record First Quarter fiscal 2023 Financial Results
OpSens Announces First SavvyWire Procedure in the US
OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures
HandySens-M Single-Channel Signal Conditioner
HandySens-G Single-Channel Unit for Temperature Measurement
OPP-M200 (Bare) - MEMS-Based Fiber Optic Pressure Sensor
OTG-MPK5: GaAs-Based Fiber Optic Temperature Sensor
OTG-M220: GaAs-Based Fiber Optic Temperature Sensor
OTG-M1400: GaAs-Based Fiber Optic Temperature Sensor
OTG-M360: GaAs-Based Fiber Optic Temperature Sensor
OTG-M3000: GaAs-Based Fiber Optic Temperature Sensor
OPP-M200 (PEEK Encapsulation) - MEMS-Based Fiber Optic Pressure Sensor
OPP-M200 (PIT Encapsulation) - MEMS-Based Fiber Optic Pressure Sensor
OTG-M170: GaAs-Based Fiber Optic Temperature Sensor